Ryan Specialty Holdings Inc has a consensus price target of $68 based on the ratings of 18 analysts. The high is $90 issued by Morgan Stanley on December 5, 2024. The low is $35 issued by Autonomous Research on February 21, 2023. The 3 most-recent analyst ratings were released by Barclays, Wells Fargo, and Keefe, Bruyette & Woods on April 11, 2025, April 10, 2025, and April 9, 2025, respectively. With an average price target of $74.67 between Barclays, Wells Fargo, and Keefe, Bruyette & Woods, there's an implied 5.73% upside for Ryan Specialty Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/11/2025 | Buy Now | 17.53% | Barclays | Alex Scott62% | $88 → $83 | Maintains | Overweight | Get Alert |
04/10/2025 | Buy Now | -6.54% | Wells Fargo | Elyse Greenspan75% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
04/10/2025 | Buy Now | — | TD Cowen | Andrew Kligerman71% | — | Initiates | → Buy | Get Alert |
04/09/2025 | Buy Now | 6.2% | Keefe, Bruyette & Woods | Meyer Shields80% | $76 → $75 | Maintains | Outperform | Get Alert |
02/26/2025 | Buy Now | 18.95% | UBS | Brian Meredith79% | $82 → $84 | Maintains | Buy | Get Alert |
02/21/2025 | Buy Now | 1.95% | RBC Capital | Scott Heleniak80% | $73 → $72 | Maintains | Sector Perform | Get Alert |
02/21/2025 | Buy Now | — | Citizens Capital Markets | Matthew Carletti83% | — | Reiterates | Market Perform → Market Perform | Get Alert |
02/21/2025 | Buy Now | -2.29% | Wells Fargo | Elyse Greenspan75% | $64 → $69 | Maintains | Equal-Weight | Get Alert |
02/21/2025 | Buy Now | 7.62% | Keefe, Bruyette & Woods | Meyer Shields80% | $77 → $76 | Maintains | Outperform | Get Alert |
01/14/2025 | Buy Now | -9.37% | Wells Fargo | Elyse Greenspan75% | $68 → $64 | Maintains | Equal-Weight | Get Alert |
01/10/2025 | Buy Now | 9.03% | Keefe, Bruyette & Woods | Meyer Shields80% | $79 → $77 | Maintains | Outperform | Get Alert |
12/05/2024 | Buy Now | 27.44% | Morgan Stanley | Bob Huang72% | → $90 | Initiates | → Overweight | Get Alert |
11/21/2024 | Buy Now | 24.61% | Barclays | Alex Scott62% | $76 → $88 | Maintains | Overweight | Get Alert |
10/10/2024 | Buy Now | 18.95% | B of A Securities | Grace Carter68% | $75 → $84 | Maintains | Buy | Get Alert |
10/10/2024 | Buy Now | -0.88% | Wells Fargo | Elyse Greenspan75% | $63 → $70 | Maintains | Equal-Weight | Get Alert |
10/09/2024 | Buy Now | 1.95% | Goldman Sachs | Robert Cox66% | $64 → $72 | Maintains | Neutral | Get Alert |
09/24/2024 | Buy Now | 6.2% | BMO Capital | Michael Zaremski73% | $65 → $75 | Upgrade | Market Perform → Outperform | Get Alert |
09/04/2024 | Buy Now | 7.62% | Barclays | Alex Scott62% | → $76 | Initiates | → Overweight | Get Alert |
08/13/2024 | Buy Now | 7.62% | UBS | Brian Meredith79% | $67 → $76 | Maintains | Buy | Get Alert |
08/05/2024 | Buy Now | -9.37% | Goldman Sachs | Robert Cox66% | $58 → $64 | Maintains | Neutral | Get Alert |
08/02/2024 | Buy Now | -20.7% | JP Morgan | Jimmy Bhullar67% | $54 → $56 | Maintains | Underweight | Get Alert |
08/02/2024 | Buy Now | -10.79% | Wells Fargo | Elyse Greenspan75% | $60 → $63 | Maintains | Equal-Weight | Get Alert |
07/23/2024 | Buy Now | -12.21% | Citigroup | Michael Ward76% | $56 → $62 | Maintains | Neutral | Get Alert |
07/11/2024 | Buy Now | -23.53% | JP Morgan | Jimmy Bhullar67% | $49 → $54 | Maintains | Underweight | Get Alert |
07/11/2024 | Buy Now | -15.04% | Wells Fargo | Elyse Greenspan75% | $58 → $60 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/09/2024 | Buy Now | -5.13% | UBS | Brian Meredith79% | $63 → $67 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | -12.21% | Keefe, Bruyette & Woods | Meyer Shields80% | $62 → $62 | Maintains | Outperform | Get Alert |
05/22/2024 | Buy Now | -5.13% | B of A Securities | Grace Carter68% | → $67 | Initiates | → Buy | Get Alert |
05/06/2024 | Buy Now | — | Wolfe Research | Bill Carcache80% | — | Downgrade | Outperform → Peer Perform | Get Alert |
04/15/2024 | Buy Now | — | JMP Securities | Matthew Carletti83% | — | Reiterates | → Market Perform | Get Alert |
04/11/2024 | Buy Now | -17.87% | Wells Fargo | Elyse Greenspan75% | $57 → $58 | Maintains | Overweight | Get Alert |
04/10/2024 | Buy Now | -12.21% | Keefe, Bruyette & Woods | Meyer Shields80% | $56 → $62 | Maintains | Outperform | Get Alert |
04/08/2024 | Buy Now | -30.61% | JP Morgan | Jimmy Bhullar67% | $47 → $49 | Maintains | Underweight | Get Alert |
02/28/2024 | Buy Now | -26.37% | Citigroup | Michael Ward76% | $49 → $52 | Maintains | Neutral | Get Alert |
02/28/2024 | Buy Now | -20.7% | Keefe, Bruyette & Woods | Meyer Shields80% | $55 → $56 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | -33.45% | JP Morgan | Jimmy Bhullar67% | $44 → $47 | Maintains | Underweight | Get Alert |
11/20/2023 | Buy Now | -24.95% | Goldman Sachs | Robert Cox66% | $57 → $53 | Downgrade | Buy → Neutral | Get Alert |
10/31/2023 | Buy Now | -30.61% | BMO Capital | Michael Zaremski73% | $53 → $49 | Downgrade | Outperform → Market Perform | Get Alert |
10/10/2023 | Buy Now | -30.61% | Citigroup | Michael Ward76% | $48 → $49 | Maintains | Neutral | Get Alert |
09/22/2023 | Buy Now | -16.45% | Wolfe Research | Bill Carcache80% | → $59 | Initiates | → Outperform | Get Alert |
09/19/2023 | Buy Now | — | JMP Securities | Matthew Carletti83% | — | Initiates | → Market Perform | Get Alert |
08/04/2023 | Buy Now | -26.37% | Barclays | Tracy Benguigui61% | $51 → $52 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | -24.95% | Wells Fargo | Elyse Greenspan75% | $50 → $53 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | -29.2% | Wells Fargo | Elyse Greenspan75% | $49 → $50 | Maintains | Overweight | Get Alert |
04/18/2023 | Buy Now | -36.28% | Citigroup | Michael Ward76% | $44 → $45 | Maintains | Neutral | Get Alert |
03/01/2023 | Buy Now | -30.61% | Wells Fargo | Elyse Greenspan75% | $47 → $49 | Maintains | Overweight | Get Alert |
02/21/2023 | Buy Now | -50.44% | Autonomous Research | — | → $35 | Initiates | → Underperform | Get Alert |
01/20/2023 | Buy Now | -27.78% | BMO Capital | Michael Zaremski73% | → $51 | Initiates | → Outperform | Get Alert |
01/18/2023 | Buy Now | -33.45% | Wells Fargo | Elyse Greenspan75% | $45 → $47 | Maintains | Overweight | Get Alert |
12/16/2022 | Buy Now | -36.28% | Wells Fargo | Elyse Greenspan75% | $41 → $45 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/15/2022 | Buy Now | -40.53% | Citigroup | Michael Ward76% | → $42 | Initiates | → Neutral | Get Alert |
11/11/2022 | Buy Now | -34.86% | RBC Capital | Mark Dwelle83% | $47 → $46 | Maintains | Sector Perform | Get Alert |
11/11/2022 | Buy Now | -41.94% | Wells Fargo | Elyse Greenspan75% | $44 → $41 | Maintains | Equal-Weight | Get Alert |
10/03/2022 | Buy Now | — | JP Morgan | Jimmy Bhullar67% | — | Downgrade | Neutral → Underweight | Get Alert |
08/12/2022 | Buy Now | — | RBC Capital | Mark Dwelle83% | — | Downgrade | Outperform → Sector Perform | Get Alert |
07/12/2022 | Buy Now | -33.45% | Goldman Sachs | Robert Cox66% | → $47 | Upgrade | Neutral → Buy | Get Alert |
05/13/2022 | Buy Now | -49.02% | Wells Fargo | Elyse Greenspan75% | $38 → $36 | Maintains | Equal-Weight | Get Alert |
The latest price target for Ryan Specialty Hldgs (NYSE:RYAN) was reported by Barclays on April 11, 2025. The analyst firm set a price target for $83.00 expecting RYAN to rise to within 12 months (a possible 17.53% upside). 29 analyst firms have reported ratings in the last year.
The latest analyst rating for Ryan Specialty Hldgs (NYSE:RYAN) was provided by Barclays, and Ryan Specialty Hldgs maintained their overweight rating.
The last upgrade for Ryan Specialty Holdings Inc happened on September 24, 2024 when BMO Capital raised their price target to $75. BMO Capital previously had a market perform for Ryan Specialty Holdings Inc.
The last downgrade for Ryan Specialty Holdings Inc happened on July 11, 2024 when Wells Fargo changed their price target from $58 to $60 for Ryan Specialty Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ryan Specialty Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ryan Specialty Hldgs was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
While ratings are subjective and will change, the latest Ryan Specialty Hldgs (RYAN) rating was a maintained with a price target of $88.00 to $83.00. The current price Ryan Specialty Hldgs (RYAN) is trading at is $70.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.